Cargando…

CDC37 as a novel target for the treatment of NPM1-ALK expressing anaplastic large cell lymphomas

Detalles Bibliográficos
Autores principales: Kuravi, Sudhakiranmayi, Parrott, Elizabeth, Mudduluru, Giridhar, Cheng, Janice, Ganguly, Siddhartha, Saunthararajah, Yogen, Jensen, Roy A., Blagg, Brian S., McGuirk, Joseph P., Balusu, Ramesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6351628/
https://www.ncbi.nlm.nih.gov/pubmed/30696805
http://dx.doi.org/10.1038/s41408-019-0171-2
_version_ 1783390616087953408
author Kuravi, Sudhakiranmayi
Parrott, Elizabeth
Mudduluru, Giridhar
Cheng, Janice
Ganguly, Siddhartha
Saunthararajah, Yogen
Jensen, Roy A.
Blagg, Brian S.
McGuirk, Joseph P.
Balusu, Ramesh
author_facet Kuravi, Sudhakiranmayi
Parrott, Elizabeth
Mudduluru, Giridhar
Cheng, Janice
Ganguly, Siddhartha
Saunthararajah, Yogen
Jensen, Roy A.
Blagg, Brian S.
McGuirk, Joseph P.
Balusu, Ramesh
author_sort Kuravi, Sudhakiranmayi
collection PubMed
description
format Online
Article
Text
id pubmed-6351628
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-63516282019-01-30 CDC37 as a novel target for the treatment of NPM1-ALK expressing anaplastic large cell lymphomas Kuravi, Sudhakiranmayi Parrott, Elizabeth Mudduluru, Giridhar Cheng, Janice Ganguly, Siddhartha Saunthararajah, Yogen Jensen, Roy A. Blagg, Brian S. McGuirk, Joseph P. Balusu, Ramesh Blood Cancer J Correspondence Nature Publishing Group UK 2019-01-29 /pmc/articles/PMC6351628/ /pubmed/30696805 http://dx.doi.org/10.1038/s41408-019-0171-2 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Correspondence
Kuravi, Sudhakiranmayi
Parrott, Elizabeth
Mudduluru, Giridhar
Cheng, Janice
Ganguly, Siddhartha
Saunthararajah, Yogen
Jensen, Roy A.
Blagg, Brian S.
McGuirk, Joseph P.
Balusu, Ramesh
CDC37 as a novel target for the treatment of NPM1-ALK expressing anaplastic large cell lymphomas
title CDC37 as a novel target for the treatment of NPM1-ALK expressing anaplastic large cell lymphomas
title_full CDC37 as a novel target for the treatment of NPM1-ALK expressing anaplastic large cell lymphomas
title_fullStr CDC37 as a novel target for the treatment of NPM1-ALK expressing anaplastic large cell lymphomas
title_full_unstemmed CDC37 as a novel target for the treatment of NPM1-ALK expressing anaplastic large cell lymphomas
title_short CDC37 as a novel target for the treatment of NPM1-ALK expressing anaplastic large cell lymphomas
title_sort cdc37 as a novel target for the treatment of npm1-alk expressing anaplastic large cell lymphomas
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6351628/
https://www.ncbi.nlm.nih.gov/pubmed/30696805
http://dx.doi.org/10.1038/s41408-019-0171-2
work_keys_str_mv AT kuravisudhakiranmayi cdc37asanoveltargetforthetreatmentofnpm1alkexpressinganaplasticlargecelllymphomas
AT parrottelizabeth cdc37asanoveltargetforthetreatmentofnpm1alkexpressinganaplasticlargecelllymphomas
AT muddulurugiridhar cdc37asanoveltargetforthetreatmentofnpm1alkexpressinganaplasticlargecelllymphomas
AT chengjanice cdc37asanoveltargetforthetreatmentofnpm1alkexpressinganaplasticlargecelllymphomas
AT gangulysiddhartha cdc37asanoveltargetforthetreatmentofnpm1alkexpressinganaplasticlargecelllymphomas
AT saunthararajahyogen cdc37asanoveltargetforthetreatmentofnpm1alkexpressinganaplasticlargecelllymphomas
AT jensenroya cdc37asanoveltargetforthetreatmentofnpm1alkexpressinganaplasticlargecelllymphomas
AT blaggbrians cdc37asanoveltargetforthetreatmentofnpm1alkexpressinganaplasticlargecelllymphomas
AT mcguirkjosephp cdc37asanoveltargetforthetreatmentofnpm1alkexpressinganaplasticlargecelllymphomas
AT balusuramesh cdc37asanoveltargetforthetreatmentofnpm1alkexpressinganaplasticlargecelllymphomas